examin
data
support
viral
hypothesi
atop
diseas
data
sourc
retriev
review
articl
origin
research
medlin
ovid
pubm
address
topic
interest
use
term
respiratori
viru
asthma
ige
atopi
viralinduc
wheez
studi
select
articl
select
relev
virus
role
asthma
much
data
support
viral
role
asthma
focus
rhinoviru
respiratori
syncyti
viru
epidemiolog
studi
use
factor
daycar
famili
size
surrog
infect
studi
support
negat
role
virus
develop
asthma
larg
volum
literatur
support
theori
viru
exacerb
preexist
asthma
set
inflammatori
cascad
mechanist
studi
fulli
explain
viral
infect
translat
exacerb
atop
diseas
provid
inform
mous
model
suggest
dendrit
cell
ige
fcri
critic
induct
atopi
studi
patient
take
antivir
agent
eg
ribavirin
palvizumab
support
notion
interf
respiratori
viral
infect
may
decreas
develop
atopi
conclus
mani
studi
suggest
strongli
viral
infect
may
predispos
patient
develop
asthma
atop
diseas
mechanist
studi
necessari
allow
develop
target
therapeut
prevent
translat
viral
atop
diseas
antivir
respons
interferon
mediat
often
view
prototyp
h
immun
respons
yet
know
viral
infect
aggrav
asthma
caus
symptom
similar
allerg
rhiniti
may
induc
develop
asthma
atop
diseaseal
h
hallmark
diseas
much
focu
determin
role
infect
develop
atop
diseas
stem
studi
explor
hygien
hypothesi
theori
postul
rel
increas
incid
atop
diseas
western
societi
due
increas
cleanli
howev
hygien
hypothesi
fulli
explain
increas
atopi
fail
acknowledg
role
viral
infect
play
develop
atop
diseas
viral
infect
abil
h
h
doubleedg
sword
well
understood
review
explor
data
support
refut
role
virus
develop
asthma
atop
diseas
also
provid
paradigm
develop
studi
suggest
ige
viral
infect
togeth
lead
develop
atop
diseas
retriev
review
articl
origin
research
medlin
ovid
pubm
address
topic
interest
use
term
respiratori
viru
asthma
ige
atopi
viralinduc
wheez
articl
select
relev
virus
role
asthma
review
literatur
note
essenti
avenu
viral
asthma
research
data
support
role
virus
develop
asthma
data
focus
role
virus
asthma
exacerb
data
support
role
virus
caus
atopi
evid
favor
caus
role
viral
infect
asthma
develop
includ
studi
focus
specif
virus
well
sever
epidemiolog
studi
document
role
viral
exposur
factor
daycar
famili
size
strongest
evid
come
studi
explor
role
respiratori
syncyti
viru
rsv
rsv
singlestrand
rna
paramyxoviru
infect
children
year
age
although
rather
mild
cours
subset
infant
primarili
age
group
develop
sever
bronchiol
requir
hospit
sigur
cowork
show
viral
infect
individu
left
markedli
increas
risk
develop
asthma
odd
ratio
well
allerg
sensit
risk
remain
present
least
year
age
tucson
children
respiratori
studi
includ
children
document
rsv
infect
infanc
howev
unlik
studi
sigur
et
al
infect
sever
enough
requir
hospit
children
follow
longitudin
develop
asthma
atop
diseas
rsv
infect
shown
increas
risk
wheez
earli
life
risk
transient
disappear
year
age
suggest
possibl
effect
puberti
although
rsv
frequent
associ
progress
asthma
virus
also
implic
studi
perform
greec
infant
bronchiol
virus
detect
nasopharyng
wash
group
found
polymeras
chain
reaction
pcr
rhinoviru
isol
basi
sheer
number
viral
exposur
rhinoviru
import
pathogen
develop
acut
bronchiol
infant
studi
document
associ
rhinoviru
infect
develop
wheez
later
life
childhood
origin
asthma
coast
studi
examin
suburban
children
birth
year
age
high
risk
asthma
parent
asthma
allergi
studi
show
import
risk
factor
develop
wheez
third
year
life
symptomat
rhinoviru
infect
associ
wheez
prior
rhinoviru
infect
stronger
rsv
viral
pathogen
coast
studi
involv
multivari
analysi
attempt
correct
factor
pet
older
sibl
particip
daycar
breastfeed
atop
dermat
presenc
food
specif
ige
take
factor
account
rhinoviru
found
associ
later
wheez
analysi
cytokin
profil
cohort
suggest
children
impair
h
respons
decreas
releas
interferon
cord
blood
monocyt
increas
number
viral
infect
first
year
life
studi
made
similar
conclus
regard
role
rhinovirus
develop
asthma
recent
studi
children
found
wheez
rhinoviru
led
strong
risk
develop
asthma
year
age
rhinoviru
look
mous
model
asthma
well
found
worsen
underli
asthmat
inflamm
airway
hyperrespons
studi
kusel
et
al
look
risk
wheez
year
age
patient
high
risk
develop
asthma
patient
initi
enrol
infant
monitor
respiratori
infect
well
period
check
asthma
atopi
year
age
patient
current
wheez
asthma
higher
rate
respiratori
infect
rhinoviru
rsv
interestingli
associ
viral
infect
wheez
asthma
limit
subgroup
patient
develop
allerg
sensit
younger
year
find
suggest
role
viral
infect
develop
allerg
sensit
parainfluenza
virus
may
also
implic
develop
asthma
parainfluenza
virus
group
rna
virus
associ
croup
pneumonia
bronchiol
infant
canadian
asthma
primari
prevent
studi
studi
children
atop
famili
perform
serial
viral
pcr
sampl
month
found
children
parainfluenza
infect
first
year
life
higher
odd
develop
asthma
second
year
life
studi
sweden
examin
cytokin
profil
children
infect
rsv
influenza
parainfluenza
found
compar
increas
h
cytokin
profil
infect
children
younger
month
thu
similar
exist
rna
respiratori
virus
abil
skew
toward
atop
predisposit
epidemiolog
data
contribut
idea
virus
may
caus
asthma
atop
diseas
studi
look
exposur
daycar
increas
famili
size
surrog
viral
exposur
studi
sweden
enrol
children
use
questionnair
document
multipl
airway
infect
daycar
attend
found
risk
factor
asthma
recent
tennesse
cohort
children
examin
see
percentag
children
asthma
year
age
bronchiol
infant
season
bronchiol
occur
increas
risk
asthma
found
children
episod
bronchiol
nonwint
month
addit
bronchiol
month
associ
higher
rhinoviru
exposur
greater
risk
develop
childhood
asthma
develop
infect
month
rsv
primari
caus
bronchiol
also
found
patient
born
month
winter
viru
peak
increas
risk
develop
asthma
thu
emphas
time
viru
play
crucial
role
develop
atopi
role
daycar
risk
factor
asthma
controversi
although
studi
suggest
daycareimpart
risk
asthma
other
show
protect
effect
argu
underli
issu
daycar
may
risk
factor
actual
diagnos
infect
taken
account
associ
data
becom
robust
studi
children
parent
histori
atopi
follow
develop
asthma
wheez
eczema
show
although
daycar
particip
less
asthma
eczema
wheez
subgroupthos
matern
histori
asthmahad
higher
rate
diseas
emphas
appli
gener
assumpt
popul
whole
may
complic
percept
regard
develop
atopi
anoth
analysi
tucson
children
respiratori
studi
analyz
presenc
asthma
relat
daycar
attend
number
sibl
home
children
studi
suggest
protect
role
daycar
older
sibl
home
least
term
develop
presenc
asthma
age
year
medic
record
isra
militari
personnel
search
associ
famili
size
asthma
develop
studi
asthma
preval
increas
famili
sibl
sibl
protect
asthma
develop
presumpt
studi
sibl
number
would
surrog
viral
infect
sibl
would
reduc
number
viral
infect
risk
asthma
remain
unexplain
although
suggest
increas
viral
infect
may
increas
risk
asthma
tippingpoint
enough
exposur
assum
larger
famili
viral
infect
lead
overwhelm
h
environ
trump
h
proatop
asthmat
respons
interest
hypothesi
howev
mani
studi
need
perform
determin
inde
case
virus
known
awhil
induc
exacerb
preexist
asthma
adult
children
past
studi
found
season
pattern
asthma
admiss
correl
season
pattern
viral
infect
sever
studi
use
pcr
analysi
identifi
virus
patient
asthma
exacerb
johnston
cowork
studi
children
age
year
decreas
peak
flow
rate
asthma
exacerb
found
detect
virus
nasal
aspir
predomin
viru
identifi
rhinoviru
studi
adult
similar
result
indic
subject
symptom
upper
respiratori
tract
infect
seen
patient
asthma
exacerb
peak
flow
reduc
conjunct
viral
infect
studi
patient
asthma
exacerb
identifi
peak
flow
decreas
lmin
document
viral
infect
innerc
adult
asthma
asthma
exacerb
secondari
respiratori
tract
viral
infect
studi
also
document
acut
emerg
depart
visit
asthma
exacerb
adult
secondari
viral
respiratori
ill
thu
virus
clearli
exacerb
preexist
asthma
viral
infect
exacerb
asthma
understood
theori
propos
explain
viral
infect
abl
exacerb
asthma
reli
obviou
antiviralinduc
inflamm
drive
bronchial
hyperrepons
instig
underli
inflammatori
pathway
asthma
howev
somewhat
circular
argument
get
underli
mechanist
connect
antivir
respons
exacerb
h
diseas
asthma
inde
whether
inflammatori
respons
h
mediat
remain
unclear
mechan
viral
infect
exacerb
induc
asthma
may
via
nontcellmedi
pathway
exampl
asthmat
patient
experiment
inocul
rhinoviru
increas
nasal
granulocyt
colonystimul
factor
seen
cytokin
correl
subsequ
increas
neutrophil
airway
suggest
neutrophil
may
play
critic
role
viralinduc
asthma
exacerb
remain
seen
innat
immun
compon
critic
role
translat
viral
asthmat
diseas
although
present
data
support
role
virus
potenti
induc
asthma
studi
argu
atop
individu
predispos
develop
viral
infect
exampl
studi
pair
danish
twin
born
relationship
rsv
infect
asthma
explor
variou
mathemat
model
bestfit
model
data
support
hypothesi
asthma
risk
rsv
infect
way
around
solv
chicken
egg
argument
major
focu
research
hope
clearer
relationship
rsv
asthma
emerg
near
futur
shown
figur
time
viral
infect
well
actual
viral
pathogen
may
critic
import
determin
whether
given
infect
lead
diseas
progress
regress
aggrav
await
addit
studi
mechanist
underpin
explain
tempor
differ
diseas
express
sinc
earli
recogn
viral
infect
lead
increas
igeboth
viral
specif
nonspecif
reason
increas
role
ige
viral
ill
known
nonetheless
associ
ige
elev
viral
infect
similar
upper
respiratori
tract
viral
infect
symptom
allerg
rhiniti
suggest
possibl
caus
link
evid
possibl
link
first
report
frick
cowork
studi
children
atop
famili
see
develop
atop
diseas
small
studi
children
note
upper
respiratori
tract
infect
month
initi
develop
allerg
sensit
interest
associ
led
author
hypothes
viral
infect
might
precipit
develop
atop
diseas
cours
chicken
egg
argument
also
appli
herear
atop
individu
suscept
viral
infect
could
viral
infect
drive
atop
diseas
use
mous
model
explor
role
virus
develop
postvir
atop
diseas
model
mice
infect
mous
parainfluenza
viru
sendai
viru
develop
airway
hyperreact
mucou
cell
metaplasia
clearanc
viru
airway
chang
longlast
still
present
least
year
initi
infect
interestingli
found
highaffin
receptor
ige
fcri
express
lung
dendrit
cell
viral
infect
ige
sendai
viru
produc
infect
crosslink
dendrit
cellexpress
fcri
led
product
h
cell
chemoattract
necessari
develop
postvir
mucou
cell
metaplasia
interleukin
process
data
provid
mechanist
insight
viral
infect
might
translat
asthma
recent
begun
explor
whether
exposur
nonvir
antigen
viral
infect
would
suffici
drive
ige
product
nonvir
antigen
inde
earli
studi
note
total
ige
level
remain
elev
clearanc
viru
wherea
viral
specif
ige
level
rapidli
decreas
find
suggest
might
possibl
produc
ige
environment
antigen
consequ
viral
infect
preliminari
data
indic
inde
exposur
nonvir
antigen
critic
point
antivir
respons
may
necessari
gener
ige
nonvir
antigen
data
begun
elucid
potenti
mechan
underli
intrigu
result
report
frick
cowork
shown
figur
data
suggest
viral
infect
may
suffici
induc
atop
cycl
selfperpetu
loop
lead
increas
atop
sensit
result
initi
infect
stress
atop
cycl
base
data
mous
model
whether
similar
mechan
oper
human
remain
determin
avenu
activ
research
viral
infect
lead
develop
atop
diseas
possibl
interven
prevent
allergi
asthma
clearli
first
target
would
prevent
viral
infect
becom
plausibl
given
newli
develop
vaccin
strategi
antivir
agent
exampl
therapeut
monoclon
antibodi
rsv
palvizumab
synagi
one
option
monoclon
antibodi
direct
epitop
antigen
site
f
protein
rsv
current
american
academi
pediatr
recommend
use
highrisk
infant
rsv
season
studi
examin
longterm
outcom
asthma
particular
patient
popul
found
patient
receiv
palvizumab
lower
rate
recurr
wheez
compar
give
antivir
rsv
shown
studi
lead
trend
toward
less
atopi
recent
studi
patient
acut
rsv
studiedsom
receiv
ribavirin
group
receiv
ribavirin
rate
physiciandiagnos
wheez
decreas
along
decreas
rate
allerg
sensit
intrigu
data
suggest
prevent
earli
treatment
viral
infect
may
abl
prevent
subsequ
develop
asthma
atop
diseas
potenti
target
viral
cascad
includ
nfb
pathway
believ
role
asthma
chronic
obstruct
pulmonari
diseas
use
small
interf
rna
technolog
doublestrand
rna
introduc
interfer
silenc
express
specif
gene
area
activ
research
target
gene
involv
nfb
pathway
basi
work
mous
model
appear
target
ige
viral
infect
would
benefici
reduc
develop
postvir
atop
diseas
inde
true
omaluzimab
xolair
human
antiig
monoclon
antibodi
could
use
break
virusigedendrit
cell
atop
cycl
interf
chemokin
involv
respons
would
also
predict
product
target
block
viru
atopi
translat
actual
effect
strategi
await
largescal
clinic
trial
hope
near
futur
intervent
develop
stem
tide
atop
diseas
develop
howev
role
ige
normal
antivir
respons
understood
remain
cautiou
effect
deplet
mediat
although
juri
remain
undecid
actual
role
virus
play
develop
asthma
atop
diseas
much
data
support
role
least
focus
development
window
highli
like
underli
genet
makeup
individu
modul
respons
viral
infect
complic
studi
explor
risk
atop
diseas
viral
infect
nonetheless
studi
perform
ongo
provid
insight
help
shape
futur
therapeut
intervent
hope
rel
near
futur
treatment
develop
use
lessen
prevent
translat
viral
diseas
asthma
atopi
two
import
question
come
studieswhi
ige
produc
part
antivir
respons
could
develop
atop
diseas
hereditari
outcrop
antivir
role
ige
look
forward
futur
studi
answer
interest
vex
question
decreas
rate
allerg
sensit
e
c
studi
support
role
virus
exacerb
asthma
shown
adult
b
children
c
adult
children
neither
studi
look
role
viral
season
bronchiol
follow
occur
decreas
risk
asthma
nonwint
viru
month
b
bronchiol
month
rhinoviru
led
increas
risk
asthma
compar
rsv
c
rsvassoci
bronchiol
led
decreas
risk
asthma
asthma
rate
stay
matter
season
child
develop
bronchiol
e
asthma
rate
decreas
bronchiol
infect
epidemiolog
studi
asthma
follow
use
surrog
viral
infect
obes
b
pet
c
daycar
famili
size
e
c
answer
found
page
